Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Selected patients with hepatocellular carcinoma are candidates to receive potentially
curative treatments, such as hepatic resection or liver transplantation, but nevertheless there …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Expansion of the liver transplantation indication criteria for patients with hepatocellular
carcinoma (HCC) has long been debated. Here we propose new, expanded living‐donor …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the second cause of death due to malignancy in the
world, following lung cancer. The geographic distribution of this disease accompanies its …

Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC)
in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However …

Background Microvascular invasion (MVI) has been recognized as a risk factor for outcome
following curative resection in hepatocellular carcinoma (HCC). Because MVI can range …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …